- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04681261
Occupational Balance, Fear and Agoraphobia (OB)
December 18, 2020 updated by: Özgü İnal, Hacettepe University
Evaluation of Occupational Balance, Fear and Agoraphobia in Adults
This study was planned to investigate occupational balance, fear of Covid-19 and agoraphobia in adults during the Covid-19 pandemic.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
During the Covid-19 pandemic, the occupational balance of individuals change and the sedentary activities preferences, that pose a risk for health, increase.The outbreak also produced effects such as fear of sickness and death in addition to changing daily life and work routines, occupational balance and social participation.
This study was planned to investigate occupational balance, fear of Covid-19 and agoraphobia in adults during the Covid-19 pandemic.
Study Type
Observational
Enrollment (Actual)
699
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Merkez
-
Edirne, Merkez, Turkey
- Özgü İnal
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
adult individuals
Description
Inclusion Criteria:
between 19-65 years of age
Exclusion Criteria:
<19 years and >65 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occupational Balance Questionnaire
Time Frame: 3 months
|
The Occupational Balance Questionnaire (OBQ) is a scale that measures self-rated OB in different dimensions.
11 item in the scale is scored on a 4-point scale from 'strongly disagree' to 'strongly agree'.
The total score is obtained by summing the individual items and ranges from 0 to 33, with higher scores indicating higher OB.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 4, 2020
Primary Completion (Actual)
June 4, 2020
Study Completion (Actual)
June 4, 2020
Study Registration Dates
First Submitted
December 18, 2020
First Submitted That Met QC Criteria
December 18, 2020
First Posted (Actual)
December 23, 2020
Study Record Updates
Last Update Posted (Actual)
December 23, 2020
Last Update Submitted That Met QC Criteria
December 18, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020/185
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on this study is not an intervention study
-
Shanghai Mental Health CenterCompletedSchizophrenia | Cognitive Dysfunction | Neuroimaging
-
University College, LondonUniversity of LeedsUnknownMultimorbidityUnited Kingdom
-
University College, LondonUniversity of Leeds; Medical Research Council; University of EdinburghUnknownDementiaUnited Kingdom
-
Oslo University HospitalNot yet recruitingSchizophrenia | Cognitive Impairment | Social Competence
-
University of EdinburghKeele UniversityActive, not recruiting
-
Massachusetts General HospitalAstellas Pharma IncCompletedOveractive BladderUnited States
-
Stanford UniversityJan Medical, Inc.CompletedDiabetes | Diabetic KetoacidosisUnited States
-
Danone Asia Pacific Holdings Pte, Ltd.Completed
-
King's College LondonNot yet recruitingCardiac Disease
-
Japan Cardiovascular Research FoundationUnknownAtrial Fibrillation | Stroke, AcuteJapan